Article
Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy.
Clinical chemistry and laboratory medicine - 1 Dec 2010
Yang Zhe, Zhou Lin, Wu Li-Ming, Xie Hai-Yang, Zhang Feng, Zheng Shu-Sen
Abstract excerpt
BACKGROUND: Histone deacetylases (HDACs) have been reported to be poor prognostic indicators in patients with cancer. However, no data are available for the role of single nucleotide polymorphism (SNP) of class I HDAC in hepato-cellular carcinoma (HCC). Therefore, we investigated the association of class I HDAC isoforms genomic polymorphisms with risk of HCC and tumor recurrence following liver transplantation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
